Transcription factor A, mitochondrial (TFAM) (TFAM)

Transcription factor A, mitochondrial (TFAM) is a critical nuclear-encoded protein that is imported into the mitochondria to regulate the maintenance, replication, and transcription of mitochondrial DNA (mtDNA) (UniProt Q00059). It belongs to the high mobility group (HMG) box family and functions by binding to mtDNA in a sequence-independent manner to package it into nucleoids, while also binding specifically to mitochondrial promoters to initiate transcription (PubMed: 23169530). TFAM is indispensable for mitochondrial biogenesis and the maintenance of cellular energy homeostasis (NCBI Gene: 7019). Its expression is primarily regulated by the PGC-1alpha/NRF-1 signaling pathway, making it a central node in metabolic adaptation (PubMed: 29056741). In disease contexts, TFAM deficiency is associated with mitochondrial DNA depletion syndromes and neurodegeneration, whereas its upregulation is often observed in various cancers to support high metabolic demands (PubMed: 30241004). Current therapeutic research focuses on pharmacological activators like resveratrol and metformin that enhance TFAM expression to treat age-related decline and mitochondrial myopathies (PubMed: 25681460). Additionally, TFAM's role in mitochondrial-nuclear communication makes it a potential target for modulating systemic metabolism and longevity. The protein's ability to stabilize mtDNA also offers a protective mechanism against oxidative stress-induced damage.

Other names

mtTFAMTTF1TCF6TCF6L1Mitochondrial transcription factor 1Transcription factor 6

Upregulation of mitochondrial biogenesis via the PGC-1alpha/NRF-1/TFAM signaling axis; stabilization and packaging of mitochondrial DNA into nucleoids to maintain genome integrity (PubMed: 29056741).